1. Home
  2. CMTV vs PRLD Comparison

CMTV vs PRLD Comparison

Compare CMTV & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CMTV

Community Bancorp. (VT)

N/A

Current Price

$42.00

Market Cap

236.7M

Sector

N/A

ML Signal

N/A

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$3.14

Market Cap

207.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMTV
PRLD
Founded
N/A
2016
Country
United States
United States
Employees
139
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
236.7M
207.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CMTV
PRLD
Price
$42.00
$3.14
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.67
AVG Volume (30 Days)
34.2K
290.5K
Earning Date
N/A
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.21
EPS
N/A
N/A
Revenue
N/A
$12,140,000.00
Revenue This Year
N/A
$320.10
Revenue Next Year
N/A
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
73.43
52 Week Low
$29.53
$0.61
52 Week High
$42.39
$4.19

Technical Indicators

Market Signals
Indicator
CMTV
PRLD
Relative Strength Index (RSI) 84.45 53.86
Support Level $30.51 $1.02
Resistance Level N/A $4.10
Average True Range (ATR) 1.73 0.36
MACD 0.90 -0.05
Stochastic Oscillator 93.97 38.48

Price Performance

Historical Comparison
CMTV
PRLD

About CMTV Community Bancorp. (VT)

Community Bancorp Inc is a holding company that provides a complete line of personal and business banking services with personal services and solutions. The company mainly offers Business banking, Commercial real estate lending, residential real estate lending, Retail credit, Municipal and Institutional Banking, and Retail Banking. The company's primary lending products are commercial, real estate, municipal, and consumer loans. The bank offers a complete line of personal and business products and services, along with offerings for non-profit organizations, municipalities, and local governments. The Firm also engages in lending activity outside the area of its branch network, through loan production offices in Burlington, Vermont, and Lebanon, New Hampshire.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: